Angiotensin II Activation of mTOR Results in Tubulointerstitial Fibrosis through Loss of N-Cadherin

BACKGROUND/AIMS: Angiotensin (Ang) II contributes to tubulointerstitial fibrosis. Recent data highlight mammalian target of rapamycin (mTOR)/S6 kinase 1 (S6K1) signaling in tubulointerstitial fibrosis; however, the mechanisms remain unclear. Thereby, we investigated the role of Ang II on mTOR/S6K1-d...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Whaley-Connell, Adam, Habibi, Javad, Panfili, Zachary, Hayden, Melvin R., Bagree, Sarika, Nistala, Ravi, Hyder, Safwan, Krueger, Bennett, DeMarco, Vincent, Pulakat, Lakshmi, Ferrario, Carlos M., Parrish, Alan, Sowers, James R.
Formato: Artigo
Idioma:Inglês
Publicado: S. Karger AG 2011
Assuntos:
Original Report: Laboratory Investigation
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3130895/
https://ncbi.nlm.nih.gov/pubmed/21720156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000329327
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares